Tocotrienol-rich fraction with tamoxifen
Showing 1 - 25 of 4,859
Obesity Trial in Kuala Lumpur (Tocotrienol-rich fraction vitamin E (TRF), Placebo)
Completed
- Obesity
- Tocotrienol-rich fraction vitamin E (TRF)
- Placebo
-
Kuala Lumpur, MalaysiaNational University Of Malaysia
Jun 7, 2023
Chronic Kidney Diseases, Hemodialysis, Microbiota Trial in Rio de Janeiro (Tocotrienol rich fraction)
Active, not recruiting
- Chronic Kidney Diseases
- +4 more
- Tocotrienol rich fraction
-
Rio de Janeiro, RJ, BrazilDenise Mafra
Aug 11, 2021
Dietary Supplements Trial in Kaohsiung (DHEA, DHEA+CoQ10+Tocotrienol)
Recruiting
- Dietary Supplements
- DHEA
- DHEA+CoQ10+Tocotrienol
-
Kaohsiung, TaiwanDepartment of Obstetrics and Gynecology, Kaohsiung Veterans Gene
Jul 21, 2022
End Stage Liver Disease, NASH - Nonalcoholic Steatohepatitis, NAFLD - Nonalcoholic Fatty Liver Disease Trial in Indianapolis
Recruiting
- End Stage Liver Disease
- +2 more
- Tocotrienol (TCT)
- Placebo
-
Indianapolis, IndianaIU Health Unviersity Hospital
Jan 19, 2022
Breast Cancer Female Trial in Kuala Lumpur (Tocotrienol-rich Fraction (TRF))
Unknown status
- Breast Cancer Female
- Tocotrienol-rich Fraction (TRF)
-
Kuala Lumpur, MalaysiaUniversity of Malaya Medical Center
Apr 18, 2019
Breast Cancer Trial in Milano (Tocotrienol)
Completed
- Breast Cancer
-
Milano, ItalyFondazione IRCCS Istituto Nazionale Tumori
Jul 29, 2020
Diabetes, Type 2, Platelet-rich Plasma, Stromal Vascular Fraction Trial in Jakarta Pusat (SVF and aaPRP)
Completed
- Diabetes Mellitus, Type 2
- +2 more
- SVF and aaPRP
-
Jakarta Pusat, Jakarta, IndonesiaHayandra Peduli Foundation
Jun 22, 2023
Wrinkle Trial in Pulau Pinang (Facial cream with 2% palm tocotrienols extract, Base cream)
Not yet recruiting
- Wrinkle
- Facial cream with 2% palm tocotrienols extract
- Base cream
-
Pulau Pinang, MalaysiaSchool of Pharmaceutical Sciences, Universiti Sains Malaysia
Mar 14, 2023
Colorectal Cancer Metastatic Trial in Vejle (drug, dietary supplement, other)
Recruiting
- Colorectal Cancer Metastatic
- Fluorouracil
- +6 more
-
Vejle, DenmarkDepartment of Oncology, Vejle Hospital
Nov 17, 2022
Ovarian Failure, Perimenopausal Disorder, Hormone Disturbance Trial in Colchester (procedure, device, drug)
Active, not recruiting
- Ovarian Failure
- +2 more
- lipoaspiration harvest tSVF
- +5 more
-
Colchester, VermontFanny Island Campus Medical Building
Jul 18, 2022
Obesity, Heart Failure With Normal Ejection Fraction Trial in Richmond (UFA dietary recommendations)
Active, not recruiting
- Obesity
- Heart Failure With Normal Ejection Fraction
- UFA dietary recommendations
-
Richmond, VirginiaVirginia Commonwealth University
Nov 17, 2022
Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)
Not yet recruiting
- Metastatic Breast Cancer
- +3 more
- Method(s)1 Attribution
- Method(s)2 Attribution,
-
Colorado Springs, ColoradoPNAF Medical
Nov 23, 2023
Diabetic Foot Ulcer, Diabetes, Diabetic Foot Trial in Lahore (Control; Standard-of-care management, Only PRP injection, PRP +
Recruiting
- Diabetic Foot Ulcer
- +10 more
- Control; Standard-of-care management
- +3 more
-
Lahore, Punjab, PakistanStem Cell Laboratory, Jinnah Burn and Reconstructive Surgery Cen
Nov 3, 2022
CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective
Recruiting
- Breast Cancer
- +2 more
-
Erlangen, GermanyDepartment of Gynecology and Obstetrics, Erlangen University Hos
May 12, 2023
Atrial Fibrillation Trial in Kuala Lumpur (Tocotrienols, Placebo oral capsule)
Completed
- Atrial Fibrillation
- Tocotrienols
- Placebo oral capsule
-
Kuala Lumpur, MalaysiaInstitut Jantung Negara
Aug 23, 2022
Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- +7 more
- Exemestane
- +6 more
-
Birmingham, Alabama
- +499 more
Nov 15, 2022
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Bioavailability Trial in Stuttgart (Control beta-carotene supplement plus Placebo, Control beta-carotene supplement plus iron
Completed
- Bioavailability
- iron and zinc suphate supplements
-
Stuttgart, Baden-Württemberg, GermanyUniversity of Hohenheim
Apr 28, 2023
Anal Fistula Trial (PRP and PRFG in treatment of anal fistula)
Not yet recruiting
- Anal Fistula
- PRP and PRFG in treatment of anal fistula
- (no location specified)
Oct 15, 2023
Colorectal Cancer Trial in Vejle (Irinotecan 165 mg/m2 iv, Oxaliplatin 85 mg/m2 iv, Calcium folinate 200 mg/m2 iv)
Active, not recruiting
- Colorectal Cancer
- Irinotecan 165 mg/m2 iv
- +5 more
-
Vejle, DenmarkDepartment of Oncology, Vejle Hospital
Aug 16, 2022
Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)
Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States
Active, not recruiting
- Invasive Breast Carcinoma
- +3 more
- Bevacizumab
- +4 more
-
Mobile, Alabama
- +525 more
Jan 28, 2023
Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each
Recruiting
- Atypical Hyperplasia
- Lobular Carcinoma in Situ
- Tamoxifen
- +2 more
-
Evanston, Illinois
- +1 more
Jan 20, 2023
Estrogen-receptor Positive Premenopausal Early Breast Cancer
Active, not recruiting
- Early Breast Cancer
- None intervention (observational study)
-
Aviano, Italy
- +39 more
Feb 7, 2023